Dynavax Technologies Corporation (DVAX)

Exchange
NASDAQ
Symbol
DVAX
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company is headquartered in Emeryville, California.
Country
USA

Stock price

At close: October 4, 2024

  • Open
    11.25
  • High
    11.36
  • Low
    10.94
  • Close
    11.02
  • Volume
    1,410,540

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
3.85
Receivables turnover
—
Payables turnover
39.13
Working capital turnover
0.30
Days of inventory on hand (DOH)
94.77
Days of sales outstanding (DSO)
—
Number of days of payables
9.33
Fixed asset turnover
6.30
Total asset turnover
0.24
 Liquidity ratios
Current ratio
13.81
Quick ratio
11.74
Cash ratio
11.94
Cash conversion cycle
85.44
 Solvency ratios
Debt-to-assets ratio
0.00
Debt-to-capital ratio
0.00
Debt-to-equity ratio
0.00
Financial leverage ratio
1.60
Interest coverage
0.36
 Profitability ratios
Gross profit margin
12.70%
Operating profit margin
-15.75%
Pretax margin
-1.84%
Net profit margin
-2.72%
Operating return on assets (Operating ROA)
-3.71%
Return on assets (ROA)
-0.64%
Return on total capital
0.39%
Return on equity (ROE)
-1.03%